ctDNA-Clearance Maintenance Report for Osimertinib-Chemo

A serial blood-test reporting service for patients on osimertinib plus chemotherapy that tells oncologists whether the tumor's DNA has vanished from the bloodstream after induction, informing whether to continue or drop the maintenance chemo responsible for much of the regimen's severe side effects.